Closing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause

In the early hours of the evening session, U.S. equity futures were mixed, as investors continue to digest U.S. trade developments with the EU, China, and South Korea. Even with earnings season continuing into a new week, one of the most notable movers in Monday’s postmarket session is Sarepta (SRPT), which surged after the FDA recommended the removal of a voluntary hold on the company’s Elevidys for ambulatory patients.

Check out this evening’s top movers from around Wall Street, compiled by The Fly.

HIGHER AFTER EARNINGS –

• Crane (CR) up 4.75%

ALSO HIGHER –

• Sarepta (SRPT) up 48% after the FDA told Sarepta it may lift its voluntary pause on shipments of Elevidys
• ScanTech (STAI) up 41.5% after securing a Letter of Intent from Visiontec Systems for multiple SENTINEL systems
• Cadence Design (CDNS) up 6.5% after reporting quarterly results and after the DOJ said the campaign will pay over $140M in penalties to resolve an illegal sales probe

LOWER AFTER EARNINGS –

• Leslie’s (LESL) down 28.2%
• Whirlpool (WHR) down 13%
• Exelixis (EXEL) down 12.5%
• VeriSign (VRSN) down 7.5%
• NOV Inc. (NOV) down 6.8%
• Nucor (NUE) down 5.8%
• Woodward (WWD) down 3.3%
• Brown & Brown (BRO) down 2.5%

ALSO LOWER –

• Bakkt (BKKT) own 28.1% after reporting preliminary Q2 results, agreeing to sell its Loyalty business to Project Labrador Holdco, and announcing an offering of class A shares and warrants